Literature DB >> 6616442

Tumor heterogeneity: biological implications and therapeutic consequences.

G H Heppner, B E Miller.   

Abstract

Mesh：

Year:  1983        PMID： 6616442     DOI： 10.1007/bf00046903

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  169 in total

1.  Heterologous and homologous growth of transplants during the course of development of spontaneous mammary tumors in C3H mice.

Authors:  H C BROWNING
Journal:  J Natl Cancer Inst       Date:  1948-03       Impact factor: 13.506

2.  Differential tumor immunogenicity of L1210 and its sublines. I. Effect of an increased antigen density on tumor cell surfaces on primary B cell responses in vitro.

Authors:  H Fuji; E Mihich; D Pressman
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Generation of fibroblast-like cells from cloned epithelial mammary cells in vitro: a possible new cell type.

Authors:  R Dulbecco; M Henahan; M Bowman; S Okada; H Battifora; M Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

4.  Is somatic mutation the major mechanism of malignant transformation?

Authors:  H Rubin
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

5.  Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate.

Authors:  B E Miller; F R Miller; G H Heppner
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

6.  Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma.

Authors:  A Mantovani; R Giavazzi; G Alessandri; F Spreafico; S Garattini
Journal:  Eur J Cancer       Date:  1981-01       Impact factor: 9.162

7.  Phenotypic variance among cells isolated from spontaneous mouse mammary tumors in primary suspension culture.

Authors:  H D Soule; T Maloney; C M McGrath
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

8.  Heterogeneity of beta 2-microglobulin in human breast carcinoma.

Authors:  M A Weiss; J G Michael; A J Pesce; L DiPersio
Journal:  Lab Invest       Date:  1981-07       Impact factor: 5.662

9.  Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells.

Authors:  G Poste; G L Nicolson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  Effects of oxygen radical scavengers and antioxidants on phagocyte-induced mutagenesis.

Authors:  S A Weitzman; T P Stossel
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422
View more
  100 in total

Review 1.  Therapeutic application of stem cells in gastroenterology: an up-date.

Authors:  Patrizia Burra; Debora Bizzaro; Rachele Ciccocioppo; Fabio Marra; Anna Chiara Piscaglia; Laura Porretti; Antonio Gasbarrini; Francesco Paolo Russo
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

2.  Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression.

Authors:  A F Chambers; G H Denhardt; S M Wilson; J G Cairncross
Journal:  J Neurooncol       Date:  1991-08       Impact factor: 4.130

3.  Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.

Authors:  So Yeon Park; Hee Eun Lee; Hailun Li; Michail Shipitsin; Rebecca Gelman; Kornelia Polyak
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

Review 4.  Quantitative genetic analysis of tumor progression.

Authors:  V Ling; A F Chambers; J F Harris; R P Hill
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

5.  A method for partial volume correction of PET-imaged tumor heterogeneity using expectation maximization with a spatially varying point spread function.

Authors:  David L Barbee; Ryan T Flynn; James E Holden; Robert J Nickles; Robert Jeraj
Journal:  Phys Med Biol       Date:  2010-01-07       Impact factor: 3.609

Review 6.  Targeted nanoparticles for colorectal cancer.

Authors:  Bruno A Cisterna; Nazila Kamaly; Won Il Choi; Ali Tavakkoli; Omid C Farokhzad; Cristian Vilos
Journal:  Nanomedicine (Lond)       Date:  2016-08-16       Impact factor: 5.307

7.  Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.

Authors:  D Samid; S Shack; C E Myers
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.

Authors:  Vanessa Almendro; Yu-Kang Cheng; Amanda Randles; Shalev Itzkovitz; Andriy Marusyk; Elisabet Ametller; Xavier Gonzalez-Farre; Montse Muñoz; Hege G Russnes; Aslaug Helland; Inga H Rye; Anne-Lise Borresen-Dale; Reo Maruyama; Alexander van Oudenaarden; Mitchell Dowsett; Robin L Jones; Jorge Reis-Filho; Pere Gascon; Mithat Gönen; Franziska Michor; Kornelia Polyak
Journal:  Cell Rep       Date:  2014-01-23       Impact factor: 9.423

9.  Antimetastatic action and toxicity on healthy tissues of Na[trans-RuCl4(DMSO)Im] in the mouse.

Authors:  R Gagliardi; G Sava; S Pacor; G Mestroni; E Alessio
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

10.  Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.

Authors:  Rifat Hasina; Mark E Whipple; Leslie E Martin; Winston Patrick Kuo; Lucila Ohno-Machado; Mark W Lingen
Journal:  Lab Invest       Date:  2008-02-18       Impact factor: 5.662
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.